G1 Therapeutics, Inc.
GTHX · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,469 | -$10,219 | -$10,878 | -$18,204 |
| Dep. & Amort. | $121 | $120 | $124 | $127 |
| Deferred Tax | $0 | $0 | $10,254 | -$9,670 |
| Stock-Based Comp. | $2,090 | $2,546 | $3,209 | $3,655 |
| Change in WC | -$2,643 | -$1,495 | -$5,020 | $4,181 |
| Other Non-Cash | $4,991 | $1,330 | -$10,481 | $9,334 |
| Operating Cash Flow | -$5,274 | -$8,898 | -$12,792 | -$10,577 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $1 | $0 | $0 |
| Inv. Purchases | -$36,471 | -$17,212 | -$47,147 | -$12,299 |
| Inv. Sales/Matur. | $36,700 | $22,500 | $39,500 | $19,500 |
| Other Inv. Act. | $0 | $1 | -$7,647 | $7,201 |
| Investing Cash Flow | $229 | $5,289 | -$7,647 | $7,201 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $553 | -$8,748 | $1 | -$1,689 |
| Stock Issued | $232 | $26 | $257 | $23 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$321 | $26 | -$248 | $1,711 |
| Financing Cash Flow | $232 | -$8,722 | $34 | $22 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4,813 | -$12,331 | -$20,405 | -$3,354 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,950 | $32,281 | $52,686 | $56,227 |
| End Cash | $15,137 | $19,950 | $32,281 | $52,873 |
| Free Cash Flow | -$5,274 | -$8,898 | -$12,792 | -$10,577 |